• OPEN AN ACCOUNT
Indian Indices
Sensex
73,598.67 -8.08
( -0.01%)
Global Indices
Nasdaq
52,379.88 143.72
(0.28%)
Dow Jones
7,698.05 53.37
(0.70%)
Hang Seng
63,411.54 1,221.89
(1.96%)
Nikkei 225
10,685.39 -81.94
(-0.76%)
Forex
USD-INR
94.93 0.33
(0.34%)
EUR-INR
106.36 0.18
(0.17%)
GBP-INR
126.93 0.23
(0.18%)
JPY-INR
0.61 0.00
(0.53%)

EQUITY - MARKET SCREENER

Tata Elxsi Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
500408
INE670A01012
467.5001455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATAELXSI
32.24
23228.51
EPS(TTM)
Face Value()
Div & Yield %
115.63
10
2.01
 

Conart Engineers bags Rs 15 cr order from Apothecon Pharmaceuticals
May 27,2026
The contract involves civil construction work for LVAPI-6 services at PO Dabhasa, Padra, Vadodara district, Gujarat, and is scheduled to be executed within 12 months from the date of the purchase order.

The company stated that neither its promoters nor promoter group entities have any interest in the awarding authority, adding that the transaction does not qualify as a related-party transaction.

Conart Engineers is engaged in providing engineering, procurement, and construction (EPC) and contracting services for industrial, commercial, and infrastructure projects.

The company reported a 190.5% surge in consolidated net profit to Rs 0.61 crore on a 10.24% increase in revenue to Rs 15.61 crore in Q3 FY26 as compared with Q3 FY25.